1
Return

Risk factors and outcomes of Pneumocystis jirovecii pneumonia after allogeneic hematopoietic stem cell transplantation for hematological malignancy: A 10-year cohort study

delete2026-06-17
delete0
PRE
AI
Q
Qiusha Huang
H
Haoyue Cui
X
Xiaolu Zhu
Y
Yun He
H
Haixia Fu
Y
Yao Chen
Y
Yuhong Chen
C
Chenhua Yan
Y
Yuanyuan Zhang
Y
Yifei Cheng
F
Fengrong Wang
T
Tingting Han
Y
Yuqian Sun
X
Xiaodong Mo
Y
Yu Wang
Y
Yingjun Chang
X
Xiangyu Zhao
L
Lanping Xu
X
Xiaojun Huang
张
张晓慧 (Xiaohui Zhang) *
DOI：10.1016/j.jtct.2026.03.033delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• Late-onset PJP exceeds 29% despite standard 6-month prophylaxis. • Age >45 years, peak corticosteroid dose, and lower CD4+ T cell count independently predict PJP. • PJP increases non-relapse mortality and reduces overall survival and disease-free survival. • Individualized prophylaxis strategy is needed for high-risk patients.

Journal

Transplantation and Cellular Therapy cover
Transplantation and Cellular Therapy
IF:
4.4
Papers:
2.1K
Citations:
4.4K

Organization

P
peking university
Scholars:
11.5W
Papers: 8.6W
Citations: 146
Cited Papers

Cited Papers

Citing Papers

Citing Papers